Advanced Biomedical Concept is an Italian medtech company reimagining what biological solutions can do for breast reconstruction. Founded in Rome in 2020, we build technologies that give surgeons more control and patients better starting conditions. Exashape is our bilayer acellular bovine pericardium matrix for prepectoral and subpectoral reconstruction. Its dual-surface design works with the body, supporting integration and guiding tissue regeneration from day one, with a range of configurations to match how you operate. Exafat is our all-in-one fat grafting system, developed for breast surgery. Its closed-loop dialysis process cleans and refines the graft in a single continuous flow, keeping viable tissue intact and your workflow simple. Behind both sits a growing body of clinical evidence, hands-on technique guides, and a dedicated e-learning platform, trusted by surgeons across more than 25 countries. Come find us at Stand 22.

Established in 1975, amoena is the world’s leading breast care brand, dedicated to supporting women’s confidence, helping them live active, fulfilling lives after breast cancer. Our products combine advanced technology with exceptional comfort, offering an extensive range of bras, swimwear, breast prostheses and breast symmetry solutions designed to support women through every stage of their breast cancer journey. Effective compression and support are vital in the days following surgery, helping to reduce discomfort, stabilise sensitive scar tissue, minimise swelling and lower the risk of post-operative oedema. Our post-surgical compression bras are specifically designed to deliver controlled support during this phase, promoting optimal healing and patient comfort. We work closely with both breast-operated women and surgeons to ensure our portfolio reflects the latest surgical techniques and the evolving needs of women after breast surgery. Our Recovery Care bras are also ideal for augmentation, reconstruction and reduction procedures, supporting healing and helping achieve optimal results.

Triangle Triangle Surgical Ltd is a leading UK medical device company with more than 30 years' experience, dedicated to bringing innovative, clinically proven technologies to the aesthetic, plastic surgery and dermatology markets. We work closely with surgeons, clinics and healthcare professionals across the United Kingdom to deliver world-class solutions that improve patient outcomes and advance clinical practice. As the exclusive UK representative for Renuvion® by Apyx Medical, Triangle Surgical is proud to offer one of the world's most advanced and widely recognised technologies for soft tissue contraction and skin tightening. Renuvion combines proprietary radiofrequency (RF) energy with helium plasma to deliver precise, controlled energy beneath the skin, providing surgeons with a powerful solution for treating skin laxity with exceptional accuracy and consistency. The technology is supported by extensive clinical evidence and has become a trusted choice for leading aesthetic surgeons worldwide. Our mission is to introduce innovative technologies that enable clinicians to deliver safer, more effective and minimally invasive treatments. By partnering with globally respected manufacturers, we ensure our customers have access to market-leading solutions that are backed by science, regulatory approvals and continuous product development.

Kent Imaging, is a leading innovator in advanced diagnostic imaging, developing, manufacturing, and marketing medical technology that supports real-time decision-making in wound care, vascular, and surgical subspecialties. Through patented imaging technologies, Kent continues to provide innovative solutions that aid healthcare systems nationally and internationally.  The Snapshot family includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device and SnapshotGLO, a bacterial autofluorescence imaging device. SnapshotNIR is supported by strong clinical evidence demonstrating its ability to improve clinical decision-making and reduce healing time, while SnapshotGLO brings new unfiltered insight into wound bioburden detection and monitoring. Together, the Snapshot family enhances clinicians’ ability to detect, direct, and protect—promoting consistency of treatment, improving outcomes, and advancing the standard of care for patients worldwide.

Establishment Labs® Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®. Our latest technology, JOY.(dot), has recently been launched globally. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica, and have been on the market, in over 80 countries, for more than a decade. In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implants® clinical trial in the United States. The four-year results have consistently reported rates of less than 1 % device-related complications leading to reoperation.

Nonacus Clinical Services is a Birmingham-based private laboratory delivering accredited clinical genomic services to the NHS and private sector. Quality underpins everything we do, demonstrated by our ISO 15189 and CQC accreditations. Our GALEAS Hereditary Cancer testing service offers non-invasive saliva sampling to identify genetic variants associated with inherited cancer, including breast, ovarian, prostate, colorectal cancers and more. This service is designed for patients diagnosed with cancer, those with a family history of cancer or individuals curious about their genetic predisposition to cancer. The end-to-end clinical service delivers an average turnaround time of three weeks. Clinicians can refer patients directly, or we also offer a pathway for self-referring patients to receive the support and guidance of our partnered genetic counsellor before and after testing. Visit us to find out how we can support your patients

For more than 40 years, POLYTECH Health & Aesthetics has been advancing breast aesthetics, reconstruction, and body contouring through innovation, precision craftsmanship, and a commitment to quality. Trusted by surgeons in more than 90 countries, with millions of implants placed worldwide, we partner with healthcare professionals to deliver individualized solutions that meet the diverse needs of surgeons and patients. Our portfolio, built around the B-Lite®, Microthane®* PRO, and MESMO® brands, represents one of the industry’s most comprehensive ranges of breast implants. From the world’s first lightweight breast implant¹ to advanced micropolyurethane surface technology and a broad selection of implant shapes, sizes, and projections, we believe every patient deserves a solution tailored to their individual anatomy and surgical goals. Innovation extends beyond our products. Through the POLYTECH Academy, we support surgeon education and the continuous exchange of clinical knowledge. At the same time, we are committed to responsible manufacturing. Our Microthane®* PRO implants are produced using a fully cured shell and adhesive foam assembly, reducing waste while maintaining the highest standards of quality and consistency. As a German manufacturer with more than four decades of experience, POLYTECH continues to shape the future of breast aesthetics through scientific evidence, quality, and meaningful innovation. Sources ¹ Govrin-Yehudain et al. Aesthetic Surgery Journal. 2018. doi:10.1093/asj/sjy071. * European patent application EP26184379.1 of 10.06.2026

Raise Healthcare is a UK-based specialist medical device distributor providing high-quality solutions to the healthcare industry. We are the proud exclusive supplier of the world’s first and only pre-shaped porcine acellular dermal matrix (ADM) for pre-pectoral breast reconstruction, Braxon Fast®. With over 80 peer-reviewed publications, our ADM is the most studied device on the market. Supplemented by Native 3D® for mastopexy and sub-pectoral reconstruction. BioBridge®, the world’s first device designed for the restoration of lymphatic function, is a novel nanoweave collagen matrix used in the surgical management of lymphoedema. This is complemented by the AROA product line, which utilises extracellular matrix technology to support soft tissue regeneration, wound healing, and tissue remodelling across a range of surgical applications. NATROX O2®, which promotes active wound healing through topical oxygen therapy, is a further addition to the Raise Healthcare portfolio. We are a progressive company that places strong value on customer relationships, underpinned by the core principles of delivering high-quality products supported by robust clinical evidence, comprehensive professional education, and a commitment to cost-conscious pricing.

Silimed, present in the market since 1978, is one of the largest silicone implant manufacturers in the world. For more than 40 years, has contributed to plastic, aesthetic and reconstructive surgery promoting research, scientific studies and development of the best technologies, always in collaboration with plastic and breast surgeons. One of the objectives of technological breakthroughs in Silimed is to create implants that offer results that are increasingly better adapted to the needs of patients. For this purpose, Silimed BioDesign line was born, with five different forms of implants depending on the diverse biotype of the woman and four available textures (smooth, textured, polyurethane and nanotextured) to meet every requirement individually.

The Royal Marsden Conference Team is internationally renowned for delivering a dynamic programme of cancer study days and multidisciplinary medical conferences. As part of The Royal Marsden NHS Foundation Trust—one of the world’s leading cancer hospitals—the team is committed to advancing clinical excellence through education. Their events are designed to showcase the latest developments in cancer research, treatment innovations, and clinical best practices, keeping healthcare professionals at the forefront of oncology. Catering to a diverse audience including clinicians, researchers, trainees, and allied health professionals, all events are led by experts in oncology and related specialties. The Conference Team also provides tailored event management services for both internal and external medical education initiatives. AAI